Quick Answer
Pregabalin for generalized anxiety is approved in the European Union but not by the FDA, so U.S. use for anxiety is off-label. It can reduce anxiety and help sleep for some people, but it causes dizziness and sedation and is a Schedule V controlled substance, so New York's prescription monitoring rules apply.
Where pregabalin fits
Pregabalin is FDA-approved in the U.S. for nerve pain, fibromyalgia and as an add-on for certain seizures. Pfizer announced in 2006 that the European Commission approved it for generalized anxiety disorder in adults. In the U.S., clinicians sometimes prescribe it off-label for anxiety, usually after first-line options haven’t worked or weren’t tolerated. This guide is part of our full set of New York anxiety guides.
A 2024 Oregon Drug Use Review noted pregabalin may help decrease anxiety for people with generalized anxiety disorder when antidepressants aren’t working or aren’t tolerated, while also finding higher rates of stopping due to side effects than placebo across off-label uses. That balance of benefit and risk is why it’s usually not a first choice. Our guide on switching medications covers other options.
For New Yorkers who haven’t done well on first-line medications, pregabalin is one option to discuss carefully rather than a quick fix. The NYC Health Department noted that clinical staffing at New York State mental health clinics fell from 10.5 to 7.9 staff per 1,000 clients between 2009 and 2021. Secure video visits anywhere in New York can make it easier to start care without a commute or a long search.
Off-label prescribing, pregabalin’s status as a Schedule V controlled substance, and dizziness and sedation are the three issues that shape the decision.
How pregabalin works
Pregabalin binds to a part of calcium channels in nerve cells and reduces the release of several signaling chemicals. That calming effect is thought to explain its benefits for nerve pain and, for some people, anxiety. It usually works faster than SSRIs, sometimes within the first week. Faster onset is appealing but comes with the side effect and misuse trade-offs described here.
What off-label means
Off-label means using an approved medication for a condition not listed on its U.S. label. It’s legal and common when research supports the use. It also means insurance may require prior authorization, and prescribers should explain the evidence and alternatives. Asking why a medication is recommended is always reasonable.
Because pregabalin’s anxiety use is off-label in the United States, it rarely appears in patient leaflets about anxiety, which can leave people confused about why it’s being discussed. The honest summary is that it has evidence for generalized anxiety, it’s used routinely for anxiety in some other countries, and it carries real side effects and misuse risk. That combination makes it a reasonable second- or third-line option for some people, not a first step for most.
Weighing pregabalin
| Consideration | What to know |
|---|---|
| U.S. status | Off-label for anxiety |
| Common side effects | Dizziness, sleepiness, weight gain |
| Controlled status | Schedule V; NY monitoring rules apply |
| Stopping | Should be tapered, not stopped suddenly |
| Coverage | May need prior authorization |
Misuse and safety
Pregabalin can be misused, especially by people with a history of substance use, and combining it with opioids, alcohol or benzodiazepines raises the risk of dangerous sedation. Your prescriber will ask about these carefully. Our guides on mirtazapine and switching medications cover related topics.
Pregabalin questions for New York patients
Because pregabalin is a controlled substance, New York’s I-STOP rules apply to prescribing. Visits run by secure video anywhere in New York, while you’re physically in the state. The practice is in-network with Aetna and Cigna; confirm your New York plan with the office, and see self-pay fees on the Good Faith Estimate page.
Questions to ask your prescriber
- Why pregabalin rather than another option?
- What dose would we start with?
- How will it affect driving and work?
- How would we stop it later?
- Will my plan cover it?
Driving and daily life
Dizziness and sleepiness can affect driving, especially when starting or increasing the dose. Many people are advised to see how they respond before driving or operating machinery. Alcohol worsens these effects. If you commute by car, plan the start carefully. Tell your prescriber if side effects affect work.
Pregabalin compared with other options
Compared with SSRIs and SNRIs, pregabalin may work faster, and it doesn’t typically cause the sexual side effects some people have with antidepressants. On the other hand, it causes more dizziness and sleepiness, can lead to weight gain, and carries misuse potential that SSRIs don’t. Compared with benzodiazepines, it has a different risk profile but still needs caution, especially with alcohol or opioids. Buspirone is another non-controlled option some people try first. Your prescriber can walk through how each option fits your symptoms and history.
Whatever you decide, the choice should be made together, with clear expectations about benefits, side effects and how you’d stop if needed.
Key Takeaways
- Pregabalin was approved for generalized anxiety disorder in the European Union in 2006.
- It isn't FDA-approved for anxiety, so U.S. use for anxiety is off-label.
- An Oregon Drug Use Review found pregabalin may help GAD when antidepressants don't work or aren't tolerated.
- It's a Schedule V controlled substance with potential for misuse.
The Bottom Line
Pregabalin for Generalized Anxiety is common and treatable, and careful care can make daily life feel more manageable.
Frequently Asked Questions
Is pregabalin approved for anxiety?
Pregabalin was approved for generalized anxiety disorder in the European Union in 2006, but it isn't FDA-approved for anxiety in the United States, where it's approved for nerve pain, fibromyalgia and as an add-on for certain seizures. Prescribing it for anxiety here is off-label. Off-label use is legal and common when evidence supports it. Your prescriber will explain the reasoning and trade-offs. Asking about alternatives is always reasonable.
When is pregabalin considered for anxiety?
It's usually considered after first-line treatments, such as SSRIs, SNRIs or therapy, haven't helped enough or weren't tolerated. A 2024 Oregon Drug Use Review noted it may help generalized anxiety in that situation. It's sometimes useful when anxiety comes with poor sleep. It's less suitable for people with a history of substance misuse. Decisions are made case by case.
What are the side effects of pregabalin?
Common side effects include dizziness, sleepiness, trouble concentrating, weight gain and swelling. These can affect driving and work, especially early on. Combining pregabalin with alcohol, opioids or benzodiazepines can cause dangerous sedation. Stopping suddenly can cause withdrawal symptoms, so it should be tapered. Report side effects to your prescriber.
Is pregabalin a controlled substance?
Yes, pregabalin is a Schedule V controlled substance in the U.S. because of its potential for misuse. In New York, the I-STOP law requires prescribers to check the Prescription Monitoring Program before prescribing many controlled substances. All prescriptions are sent electronically. These rules help keep prescribing safe. Your prescriber will explain what applies.
Can I stop pregabalin on my own?
No, pregabalin should be tapered rather than stopped suddenly, since abrupt stopping can cause symptoms like trouble sleeping, nausea, headache and anxiety. Your prescriber will plan a gradual reduction. If side effects are a problem, contact the office rather than stopping. A planned taper is safer. Keep follow-ups during the taper.
Can pregabalin be prescribed by telehealth in New York?
Controlled substance prescribing by telehealth follows federal and New York rules, including I-STOP monitoring and electronic prescribing. Your prescriber will explain what's possible in your situation. Many other anxiety medications aren't controlled and can be prescribed routinely by video. You need to be physically in New York during visits. Ask the office if you have questions.
Where to go from here
- Right now, if you're not safe
- Call or text 988, or call 911.
- If you'd like an evaluation
- See how scheduling and telehealth work on the new patient page.
- If you want to keep reading
- Return to our New York anxiety guide for more guides.
How We Reviewed This Page
Written by Steven Lockhart of Health Marketing Group and clinically reviewed by Gabriella I. Farkas, MD PhD, a board-certified psychiatrist. Clinical information comes from the sources listed below, and the page is reviewed every 180 days or when guidance changes.
What’s new: September 29, 2026. Page published.
References
- Oregon Drug Use Review. Gabapentinoid off-label use review (2024). https://www.orpdl.org/durm/meetings/meetingdocs/2024_06_06/finals/GabapentinoidoffLabelreview.pdf
- Pfizer. European Commission approves Lyrica for generalized anxiety disorder (via Medical News Today). https://www.medicalnewstoday.com/releases/40404.php
- New York State Senate. New I-STOP Law To Help State Fight Prescription Drug Abuse (2012). https://www.nysenate.gov/newsroom/press-releases/2012/velmanette-montgomery/new-i-stop-law-help-state-fight-prescription
- NYC Health Department. The State of Mental Health of New Yorkers (2024). https://www.nyc.gov/assets/doh/downloads/pdf/mh/state-of-mental-health-new-yorkers.pdf
- 988 Suicide & Crisis Lifeline. https://988lifeline.org/